Back to results
US 10,206,957 B2Granted
Use of gram negative species to treat atopic dermatitis
AssigneeThe United States of America, as represented by the Secretary, Department of Health and Human Services
InventorsIan Antheni Myles, Sandip K. Datta
Life of this patent
Estimating the term…
Abstract
Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
Claims13
A method for treatment of atopic dermatitis, comprising:
- topically administering a composition comprising at least one strain of Roseomonas mucosa to a subject in need thereof, wherein the at least one strain of Roseomonas mucosa is present in an amount sufficient for treatment of atopic dermatitis in the subject, and wherein the at least one strain of Roseomonas mucosa is isolated from a donor that does not have atopic dermatitis.
Dependencies are inferred from the claim text.